Creon 36000 [USP'U]/1

Pancrelipase, the active ingredient in Creon 36000, is a pancreatic enzyme replacement therapy presented as a 36000 USP units per capsule, delayed-release pellets for oral use. It is used to treat exocrine pancreatic insufficiency in conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, and post-pancreatectomy. GNH USA supplies Creon 36000 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Creon 36000 is designed to provide essential enzymes that aid in the digestion of fats, proteins, and carbohydrates, helping patients manage symptoms of pancreatic insufficiency.

Creon 36000 is used to manage exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. This drug helps improve digestion and nutrient absorption in patients with various pancreatic disorders.

- Cystic fibrosis: Improves digestion and nutrient absorption in patients with cystic fibrosis. - Chronic pancreatitis: Helps manage symptoms of chronic pancreatitis by aiding digestion. - Pancreatic cancer: Assists in digestion for patients who have undergone pancreatic surgery or have pancreatic cancer. - Post-pancreatectomy: Supports digestion in patients who have had part or all of their pancreas removed.

Creon 36000 may cause side effects, although not everyone gets them. Common side effects include gastrointestinal discomfort, while serious or rare side effects are less frequent but more severe.

Common Side Effects: - Stomach pain: Mild to moderate abdominal discomfort. - Diarrhea: Loose or watery stools. - Nausea: Feeling sick to the stomach. - Vomiting: Expelling stomach contents through the mouth. - Headache: Pain in the head. - Cough: Persistent coughing.

Serious or Rare Side Effects: - Fibrosing colonopathy: A serious condition affecting the colon. - Allergic reactions: Severe allergic responses, including rash, itching, and swelling. - Hyperuricemia: Elevated levels of uric acid in the blood. - Rectal bleeding: Bleeding from the rectum.

Creon 36000 should be used with caution and under medical supervision. It is important to follow the prescribed dosage and monitor for any adverse effects.

- Dosage adjustment: Regular monitoring of body weight and stool fat content is recommended. - Allergic reactions: Discontinue use and seek medical attention if an allergic reaction occurs. - Fibrosing colonopathy: High doses may increase the risk of this condition. - Lactose intolerance: Contains lactose, which may not be suitable for lactose-intolerant patients. - Store at room temperature: Keep the medication in a dry place and in the original container. Store between 15°C and 30°C, away from light and moisture.

Creon 36000 may interact with other medications, which can affect its efficacy or increase the risk of side effects. It is important to inform your healthcare provider about all medications you are taking.

Major Interactions (Avoid): - Antacids: May reduce the effectiveness of Creon 36000 by altering stomach pH. - H2-receptor antagonists: Can interfere with the release of enzymes in the intestine.

Moderate Interactions (Monitor Closely): - Iron supplements: May reduce the absorption of iron. - Folic acid supplements: May require dosage adjustment. - Vitamin supplements: May need to be taken separately from Creon 36000.